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Abstract:  
The health care industry is one ofhuge part of world industries today. With such a huge customer based and an 
increasing demand, pharmaceutical industries will respond to patient’s demands by developing and successfully 
expanding their technologies. The nature of newly discovered drugs becomes more complex and toxicity also 
increased, new novel modes of delivery are necessary to deliver them to the desired sites of the body. Due to this 
reason the renowned pharmaceutical companies are concentrating on applying new methods and technologies. As 
compared to other technologies pharmaceutical nanotechnology is one of the most comprehensive technologies. 
Pharmaceutical nanotechnology gives novel tools with lots of opportunities and scope, which are expected to have a 
great impact not only on complicated diagnosis of disease but also on the therapeutics of diseases. Due to this 
advances, pharmaceutical nanotechnology is now popular and well-established for diagnostics, drug delivery and 
treatment of diseases through its nano-structured tools & devices. Pharmaceutical nanotechnology assists to 
develop novel technologies where current existing and conventional technologies may have their limits.It also 
provides opportunities to improve materials, medical devices performance. Due to current novel development in 
nano-technology, global interest shown by scientists, governments and industries assure that there is enormous 
potential and huge scope of nano-technology based drug delivery system in near future. 
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INTRODUCTION: 
Nanotechnology is a rapidly growing science of 
producing and utilizing nano-sized particles that they 
are having very small size, that measure in nano-
meter. In other words, nanotechnology is the art of 
characterizing, manipulating and organizing matter 
systemically, at the nano-meter scale, which has 
created a revolution in all research perform in 
science, engineering, technology, drug delivery and 
therapeutics. The normal size of accessible structures 
is resides in the sub-micrometer range, being within 
the limits of optical resolution and visible barely with 
a light microscope. This scale is very smaller than 
structures that could be resolved by the naked eye, 
but still 1000 times larger than an atom. The 
nanotechnology is defined as developmentof a 
novelsizestructureresides is in the nano-meter range 
and the size range below these dimensions of a 
typical structure [1]. Today there are lots of 
treatments that require a more time and are also very 
expensive too. With the utilization of nanotechnology 
in pharmaceutical field, quicker and less expensive 
treatments can be developed. Normally, drugs flows 
and travels through the whole body before it reach 
the disease affected area or site. Using 
nanotechnology pharmaceuticals, the drug can be 
targeted to a precise location which would make the 
drug much more effective and reduce the chances of 
possible side-effects [2,3]. Current development in 
Pharmaceutical Nanotechnology provides a novel 
approach and complete technology against cancer for 
early diagnosis, prediction, prevention, personalized 
therapy and targeted drug delivery of anticancer drug 
or medicine.Nanotechnology would play important 
role in target-specific drug delivery and methods for 
early diagnosis of diseases and disorders [4].  
 
Pharmaceutical Nanotechnology Based Systems 
It is a challenging task developing a drug delivery 
system that enhances the pharmaceutical action of a 
drug whilereducing its toxic side effect in vivo. By 
using pharmaceutical nano-systems these challenging 
task can controlled. Nano-materials and nano-
devicesaretwo basic type’s pharmaceutical 
nanotechnology, which play a main role in 
pharmaceutical nanotechnology and other fields.The 
nano materials, are made from biomaterials; used in 
dental implants or orthopaedic. Their 
biocompatibility with the living cells can enhances by 
surface modified or coatings. These are further 
classified into two main type nano-structure materials 
and nano-crystals [5]. Nanostructured materials are 
vital because it can bridge the gap between molecular 
& bulk levels [6]. Nanostructured materials are 
processed forms of nano-materials with special size, 
shapes and functions. These include fullerenes, 
dendrimers, carbon nanotubes, quantum dots, and 
many more [7]. Nanomaterials are widely used in 
drug delivery due to their advantages like they can 
increase drug solubility; drug targetingand can lead to 
controlled release. They are used in various drug 
deliveries like genedelivery, hormone delivery 
through the skin, drug delivery through the eye and in 
oral and vaccine delivery systems and treatment like 
targeted anti-cancer treatment. Now a day’s lot of 
companies worldwide employ nanoparticles in anti-
cancer treatment. Nano devices are very  small 
devices in the nanoscale and some of which include 
microarrays for the different kind of biological assay 
e.g. DNA, protein, cell, microfluidics for control and 
manipulation of micro or nanolitre of fluids, nano- 
and micro-electromechanical systems (NEMS/ 
MEMS), and disease signatures and some intelligent 
nano machines like respirocytes. Nanocrystals are 
prepared in special mills and the resulting nano sized 
drugscan be applied intravenously as 
nanosuspensions or bronchially through an inhaler. 
This reduced size drug size increases the 
surface/volume-ratio and altimetly enhancement in 
bioavailability of almost insoluble pharmaceuticals 
[8].  
 
TYPES OF PHARMACEUTICAL 
NANOSYSTEMS WITH THEIR 
APPLICATIONS 
The following are different types of nanosystems 
with their pharmaceutical applications  
 
Dendrimers 
Dendrimers are globular, highly branched, and 
synthetic polymers containing of an initiator core and 
multiple layers with active terminal groups. These 
layers are comprised of repeating units and each of 
these layer is called a generation. The core of a 
dendrimer is indicated as generation zero. The 
specific molecular structureof dendrimers with 
interior coremakes them suitable to carry various 
drugs using their multivalent surfaces 
throughelectrostatic adsorption or covalent 
conjugation. The advantages of dendrimers are that 
they are uniform in size to many proteins and 
biomolecules like insulin, and haemoglobin. Second 
generation dendrimers have a width similar to that of 
DNA (2.4 nm). Through hydrophobic interaction, 
hydrogen bond, or chemical linkage drugs can be 
loaded in the cavities in dendrimer cores. Researchers 
in Michigan developed a polyamidoamine-based G5 
dendrimer for targeted drug delivery to tumour.The 
polyamidoamine-based G5 dendrimer has a diameter 
of about 5 nm and more than 100 functional primary 
amines on the surface. By attaching folate as the 
targeting molecule and methotrexate as the 
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therapeutic agent, the G5 dendrimer was many folds 
more effective than methotrexate alone in prohibiting 
tumourgrowth [9]. Dendrimers used in drug delivery 
and imaging are usually 10 to 100 nm in diameter 
with multiple functional groups on their surface, 
makes them ideal carriers for targeted drug delivery 
[10]. However, Dendrimers with poly cationic 
surface shown great potential in the targeted delivery 
of anticancer therapeutic agents, which can form 
multiple interactions with a number of target 
receptors. The poly cationic surface is also having 
main disadvantage in therapeutic delivery 
applications are due to their toxic effect on cell 
membranes [11]. 
 
Liposomes  
In 1976 liposomes was first described as lipid 
vesicles that was applied in drug delivery [11].In 
1995 liposomes were the first nanoscale drug 
delivery devices gets approval for clinical use. Since 
then, up to today many of developments are takes 
place in liposomes drug delivery system. Now a days 
liposomes are available not only for oral but also for 
topical and transdermal route. Long circulating 
liposomes, stimuli-responsive liposomes, elastic 
liposomes, nebulized liposomes are the new advances 
of liposomal drug delivery system [12]. Liposomes 
are spherical vesicles composed of amphiphilic 
phospholipids and cholesterol, which self-associate 
into bilayers to encapsulate an aqueous interior. The 
amphiphilic phospholipid molecules form a closed 
bilayer sphere in an attempt tostill maintaining 
contact with the aqueous phase via the hydrophilic 
head group, while shield their hydrophobic groups 
from the aqueous environment. Because a liposome 
can encapsulate an aqueous solution with a lipophilic 
outer membrane, hydrophilic solutes cannot pass 
through the lipids. So, liposomes can carry both 
lipophilic molecules as outer membrane and 
hydrophilic molecules in the inner aqueous core. 
Liposomes can be classified into three categories 
depending upon their size and number of bilayers as: 
multilamellar vesicles (multi bilayer), large 
unilamellar vesicles (large size, single bilayer), and 
small unilamellar vesicles (small size, single bilayer). 
Liposomes can be divided into five types based upon 
composition as well as mechanism of intracellular 
delivery: conventional liposomes, pH-sensitive 
liposomes, cationic liposomes, immune liposomes, 
and long-circulating liposomes [10]. The 
liposomeslipid bilayer fuse with bilayers of the cell 
membrane delivers its contents to the appropriate 
area. Liposomes have been intensivelyinvestigated 
for their use in cancer therapy. The effectiveness of 
drug delivery systems due to their small size, 
controlled time release of the drug, modification of 
drug pharmacokinetics, biological distribution and 
reduced drug toxicity [3]. 
 
Quantum dots  
Quantum dots are nanocrystal or small tiny particles 
a semi conducting material with 2-10 nanometer 
diameter. Quantum dots are first discovered in 
198013.  Quantum dots are used for periods ranging 
from milliseconds to minutes to track individual 
glycine receptors (GlyRs) and to analyse their 
dynamics in the neuronal membrane of living cells 
[14]. In recent years, semiconductor quantum dots 
have attracted the attention of many research groups 
because of their applications in scientific and 
technological significance in microelectronics, 
optoelectronics and cellular imaging [4]. Quantum 
Dots are semi conducting materials consisting of a 
semiconductor core coated by a shell to improve 
optical properties. Their properties originate from 
their physical size which ranges from 20-200A⁰ in 
diameter [7]. Quantum dots are widely used in 
biological applications that require fluorescence, 
including cell biology and immune fluoresence 
assays, DNA array technology, particularly in the 
immune staining of proteins, microtubules and 
nuclear antigens [15]. The most commonly used 
Quantum dots are cadmium telluride, cadmium 
selenide, indium, arsenide and indium phosphide. In 
bio-imaging these particles serve as contrast agents, 
providing much greater resolution than existing 
fluorescent dyes. Quantum Dots particles absorbing 
white light and re-emit it with different bulk band gap 
energies corresponding to different combinations of 
particles within nanoseconds [10]. 
 
Carbon nanotubes  
Carbon nanotubes are hexagonal networks of carbon 
atoms. Carbon nanotubes are 1nm in diameter and 1-
100nm in length. Nanotubes are of two type’s single 
walled nanotubes and multi walled nanotubes. These 
are small macro molecules have unique size, shape 
and remarkable physical properties [16]. Carbon 
nanotubes are carbon cylinders composed of benzene 
rings.Carbon nanotubeshave been used as diagnostic 
devices for the discrimination of different proteins 
from serum samples, biological sensors for detecting 
protein and DNA, and as carriers to deliver drug, 
protein or vaccine4. Single-walled carbon nanotubes 
have been usedto develop highly specific electronic 
biomolecule detectors as well as a platform for 
investigating surface–protein and protein–protein 
binding [14].  
 
Polymeric nanoparticles 
Polymeric nanoparticles having some inherent 
properties like biocompatibility, biodegradability, 
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non-toxicity and non-immunogenicity [7]. Polymeric 
nanoparticles are the combined name for nanospheres 
and nanocapsules [11]. Polymeric nanoparticles are 
solid colloidal particle with radius ranging from 0.5 
to 500 nm [17]. Polymeric nanoparticles are 
developed as effective delivery vehicles because 
itsability to enhance the efficacy and minimizes the 
side effects of chemotherapeutic drugs due to their 
passive tumour-targeting properties. Polymeric 
nanoparticles having preferentially capacity to 
accumulate in and around the tumour mass also gives 
a platform for improved diagnostics of tumour, 
hereby this property laying the foundation for the 
new development of multi-functional nanoparticle 
systems in cancer diagnosis &therapy [18]. For 
preparation of polymeric nanoparticles natural 
macromolecules, such as proteins and 
polysaccharides, non-polar lipids, metal oxides and 
silica, and Polymers like poly 
(alkylcyanocrystalates), poly (mythylidenemalnolate 
2.1.2), polyesters, e.g., poly (lactic acid), poly(e-
caprolactone), and their copolymers are used [19]. 
Polymeric nanoparticles can be used for better 
application by overcoming obstacles in conventional 
drug delivery & effective drug delivery and would 
enhance treatment & patient compliance [20].  
 
Polymeric micelles 
Now a day’s these micelles have emerged as a new 
promising colloidal carrier for targeted delivery of 
poor water soluble as well as amphiphilic drugs. 
Polymeric micelles can enhance solubilisation of 
hydrophilic compounds in their inner core. These are 
more stable as compared to surfactant micelles [21]. 
A polymer micelle is a nanoparticle consisting of two 
main parts one hydrophilic shell and one hydrophobic 
core. It can be divided into two main categories: 
hydrophobically assembled micelles and polyion-
complex micelles. The hydrophobically assembled 
micelles consist of amphiphilic copolymers with a 
hydrophobic and a hydrophilic block. Balance 
between those two blocks in an aqueous medium 
induces spontaneous formation of nano-sized 
particulates. For most block copolymers, poly 
(ethylene glycol) is used as a hydrophilic block. 
Different micelle properties originate from the nature 
of hydrophobic core-forming materials, which 
include biodegradable polyesters polymers such as 
poly (glycolic acid), poly (lactic acid), and poly (e-
caprolactone) [22]. These are usually of less than 
100nm and their hydrophilic surface inhibit uptake by 
reticuloendothelial system. Micelles formed in 
solutions as aggregates in which the component 
molecules are arranged in a spherical structure with 
hydrophobic core shield from water by a mantle of 
hydrophilic groups. These are used for systemic 
delivery of water insoluble drugs [7]. 
 
Metallic nanoparticle: 
Metallic nanoparticle can be prepared by various 
methods by using metals like gold etc. A metal 
nanoparticle shows similar optical properties which is 
dependent upon shape and size [23]. Researcher 
made nanoparticle by using various metals but out of 
all of themgoldand silver nanoparticles are important 
for biomedical use, a large number of ligands have 
been linked to nanoparticles such as peptides,sugar, 
proteins and DNA [7]. They have been used fordrug 
discovery, bioassays, active delivery of bioactive, 
detection, imaging and many other applications due 
to surface functionalization ability. Due these 
advantages it is an alternative to quantum-dots [8]. 
 
Fullerenes 
A Fullerene isentirely composed of carbon in the 
forms of hollow sphere, ellipsoid or tubular and many 
more shapes. Buckminster Fuller who designed 
geodesic physical structures and buildings based on 
this geometry, fullerenes are commonly referred to as 
“Buckyballs”. A Buckyball is a carbon consisting 
hollow geometric sphere, first found in soot 
developed from a laboratory experiment [24]. 
Fullerenes are similar to carbon nanotubes in that 
their molecular framework is entirely composed of an 
extensive p-conjugated carbon skeleton. They are 
typically synthesized by poorly understood empirical 
methods; for instance, the vaporization of graphite by 
resistive heating yields grunge from which fullerenes 
can be isolated chromatographically [25]. Fullerenes 
bind very efficiently and inactivate radicals that play 
a vital role in the development of diseases of the 
central nervous system e.g. Parkinson, Alzheimer 
diseases and cardiovascular diseases [26]. 
 
APPLICATION OF PHARMACEUTICAL 
NANOTECHNOLOGY 
From the concept of the Nanotechnology, the current 
approach to Pharmaceutical therapy in which drug is 
systemically absorbed by whole body in order to 
affect a single localized organ, according to which 
that organ, or diseased part of it , should be targeted 
with molecular precision. The pharmaceuticals in 
current rely on slight differential selectivity of 
binding or uptake, and a dose sufficient to be 
effective against the diseased organ is likely to have 
significantly deleterious effects on the body as a 
whole when weak binding and uptake are summed 
over the entire rest of the body. The pharmaceutical 
nanotechnology has been also focusing the following 
applications. 
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Drug discovery and design 
Nanotechnology is playing vital role for better 
understanding of mechanism of the drug action and 
identification of biomarker associated with specific 
disease which assist in new drug discovery and 
design. Byidentifying the protein present on the 
surface or target surface nanotechnology helps in 
identification and validation of 
target.Nanotechnology will enhance the drug 
discovery process, through miniaturization, 
automation, speed and reliability of assays. The 
examples of nanotechnology in drug discovery 
arequantum dots are used for periods ranging from 
milliseconds to minutes to track individual glycine 
receptors and to analyse their dynamics in the 
neuronal membrane of living cells, single walled 
nanotubes are successfully used to identity surface 
protein of pathogen. Similarly, gold nanoparticles, 
nanobodies which are smallest, intact, antigen-
binding fragments produced by Ablynx are some 
commonly used nanomaterials in diagnostics [27].  
 
Drug delivery 
The pharmacokinetics profile of new discovered drug 
entity can be modified by using Pharmaceutical 
nanotechnology7. Nanoparticle-based drug delivery 
has many advantages over conventional drug delivery 
system, such as enhancing drug-therapeutic 
efficiency and pharmacological characteristics. 
Because nanoparticles having advantages such 
asmodify pharmacokinetics, improve the solubility of 
poorly water-soluble drugs, improve 
bioavailability,increase drug half-life by reducing 
immunogenicity, increase specificity towards the 
target cell or tissue therefore reducing side effects, 
diminish drug metabolism and enable a more 
controllable release of therapeutic compounds and 
the delivery of two or more drugs simultaneously for 
combination therapy [28]. The nanotechnology based 
drug delivery system also used for delivery of 
miconazole to the skin [29]. Nanotechnologies endue 
drug delivery system with optimized physical, 
chemical and biological properties can serve as 
effective delivery tools for currently available 
bioactives. Few nanotechnology based drug delivery 
devices are liposome,dendrimer,polymeric 
nanoparticles, polymer-drug conjugates, polymeric 
micelles, antibody- drug conjugates, which can 
broadly be classify as (i) stimuli sensitive delivery 
system, (ii)sustained and controlled delivery system, 
(iii) intracellular, cellular, tissue site specific 
targeting, (iii) multifunctional system for combined 
delivery of therapeutics, bio-sensing and diagnostic, 
and  (iv)functional system for delivery of bioactives 
[30]. 
 
Molecular Diagnostics 
The nano science of representing, characterizing, and 
quantifying subcellular biological processes in entire 
organisms is called as Molecular imaging. These 
processes include gene expression, protein-protein 
interaction, signal transduction, cellular metabolism, 
and both intracellular and intercellular trafficking. 
Some nanoparticles such as iron oxide nanocrystal, 
quantum dots and metallic nanoparticleswhich have 
inherent diagnostic properties. They have been 
successfully utilized in various magnetic resonance 
imagings, optical imaging, ultrasonic imaging and 
nuclear imaging [31]. The combination of other 
nanotechnology-based materialswithnanoparticles 
has the potential to address this emerging challenge 
and provide technologies that makes diagnoses 
possible at the level of single molecules and single 
cells [28]. In bio-imaging quantum dots particles 
such ascadmium telluride, cadmium selenide, indium 
phosphide, and indium arsenide serve as contrast 
agents, providing much higher resolution than 
existing fluorescent dyes [10]. 
 
Tissue Engineering  
Tissue engineering makes use of artificially 
stimulated cell proliferation by using suitable 
nanomaterialbased growth 
factorsandscaffolds.Nanotechnology can assist to 
repair damaged tissueor toreproduce it. In future with 
more advances in tissue engineering might replace 
today’s conventional treatments like organ 
transplants or artificial implants [32]. 
Nanotechnologies and micro technologies can be 
merged with biomaterials to generate scaffolds for 
tissue engineering that can maintain and regulate cell 
behaviour [33]. Nanotechnology can be used to 
create Nano patterns, nanofibers and control release 
nano particles with useful application in tissue 
engineering [34]. 
 
In gene therapy 
In gene therapy, using a carrier moleculea normal 
gene is inserted in place of an abnormal 
diseasecausing gene. Conventional viral vectorsuse 
as a carrier molecule are associated with 
inflammatory reactions, adverse immunologic, and 
diseases in the host. Nanotechnology based drug 
delivery systems have currently emerged as potential 
carrierfor effective and promising tool in systemic 
gene treatment. Nanoparticles composed form 
polymer like chitosan, poly-l-lysine and modified 
silica nanoparticles have been reported to have 
enhanced transfection efficiency and reduced 
cytotoxicity. Nanotechnology provides viable option 
as ideal vector in gene delivery [35]. Nano sized 
liposomes can be used for delivery of genetic 
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material into desire cells. Liposomes incorporated 
with polyethylene glycol and galactose target liver 
cells effectively due to their rapid uptake by liver 
Kupffer cells. Thus gene therapy may be useful with 
such liposomal nanoparticles for variousliver 
disorders such ashereditary hemochromatosisand 
Wilson’s disease [25]. A polymeric nanoparticle 
givesanti-proliferative effects by targeted delivery of 
gene therapy to breast cancer cells [36]. 
 
Stem cell therapy 
Current research suggestsnanoparticles may be useful 
as effective tools for improving stem cell therapy. 
Chemical engineers have successfully used 
nanoparticles to enhance stem cells' ability to 
stimulate regeneration of damaged vascular tissue 
and reduce muscle degeneration in mice36. In stem 
cell therapy magnetic nanoparticles coupled to 
antibodies are added to a blood or bone marrow 
sample that contains the target adult stem cells. The 
magnetic particles bind the target cells, which then 
can be recovered using a magnet. This technique is 
used in cell therapies to isolate adult stem cells that 
are then retransplanted in the patient e.g. to treat 
blood disorders or cardiac diseases [26]. Theuse of 
iron oxide nanoparticles to develop 
magnetodendrimers that can be used to label human 
neural stem cells and mesenchymal stem cells 
through nonspecific membrane adsorption processes 
[37]. The use of super paramagnetic iron oxide 
particles to label human mesenchymal stem cells to 
track their migration using MRI after transplanting it 
for cartilage repair [38]. 
 
In Cancer treatment 
The research going on their conclusions shows that 
nanoparticles are useful for cancer treatments these 
includes are liposomes, quantum dots, solid lipid 
nanoparticles, nano shells, gold nanoparticles. Due to 
small size nanoparticles penetrate small capillary and 
are taken up by the cell which allows for efficient 
drug accumulation at the target sites in the body [39]. 
The effectiveness of nanotechnology based drug 
delivery systems have few advantages such as their 
small size, reduced drug toxicity, controlled time 
release of the drug and modification of drug 
pharmacokinetics and biological distribution 
overcome drawbacks of conventional anti-cancer 
drug delivery system [40]. 
 
Artificial organs and implants 
Transplantation is often the only option for many 
patients those suffering from end-stage organ failure. 
Application of nanotechnology in artificial organ and 
implant development generates hope for those 
patients.  Nanotechnology can be useful for the 
development of artificial organs and implants but still 
safety and clinical approvals yet to grant by 
respective regulatory authority. Current research and 
investigations are going on for replacement of 
defective or incorrectly functioning cells and organs 
with artificial cells [14].  
 
FUTURE ASPECTS OF PHARMACEUTICAL 
NANOTECHNOLOGY 
Now a day’s materials with nanostructure by 
combination with nanotechnology techniques are 
being used to make better composite materials, 
materials with enhanced catalytic activity, hardness 
and scratch resistance, and a wide range of consumer 
products that improve human life. Pharmaceutical 
nanotechnology has emerged as a discipline having 
tremendous potential as a carrier delivery of 
bioactives and diagnostics and provides smart 
materials for tissue engineering. It offers novel tools, 
scope and opportunities, which are anticipated to 
have a great impact on many areas in diagnostics of 
disease and treatment of diseases through its nano-
engineered tools. Pharmaceutical nanotechnology 
gives better opportunities to enhance materials, 
medical devices and assist to develop novel 
technologies where existing and more conventional 
technologies may have their limits. In coming future 
nanotechnology will provide us the new 
nanotechnology such as Nano cocoons, smart 
medicine and nanorobots to make important 
contributions to disease diagnosis, detection, therapy, 
and prevention. 
 
CONCLUSION: 
New innovations in pharmaceutical nanotechnology 
provide new tools, opportunities and scope, which are 
expected to have a great impact on many areas in 
disease diagnostics and therapeutics. Pharmaceutical 
nanotechnology has emerged as a discipline having 
enormous potential as carrier for spatial and temporal 
delivery of bioactives and diagnostics and provides 
smart materials for tissue engineering. 
Pharmaceutical nanotechnology is now well-
established as specialized area for drug delivery, 
diagnostics, prognostic and treatment of diseases 
through its nanoengineered tools. Few products and 
delivery systems of nanotechnology base are already 
approved by regulatory bodies are also they in 
market. Nanotechnology creates new hope to 
pharmaceutical industries by providing new age 
patentable technologies in view of revenue loss 
caused due to off-patent drugs. Various researcher 
and scientist of scientific industries, research 
societies and governments all over world are looking 
with great expectations and contributing their best to 
discover and unleash the potential of nanotechnology. 
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Nanotechnology has the great potential to make 
remarkable contributions to disease diagnosis, 
therapy, and prevention. However, few suggested 
initiative must be taken in order to utilize the 
advantage of this growing potential of 
nanotechnology. We still don’t have sufficient data 
and guidelines regarding safe use of devices and 
materials based upon nanotechnology. There are few 
unresolved issues related with safety of 
nanotechnology. But still with all these 
considerations pharmaceutical nanotechnology have 
very good potential to solve many issue related with 
pharmaceutical industry. 
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